1. Home
  2. KURA vs SPLP Comparison

KURA vs SPLP Comparison

Compare KURA & SPLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • SPLP
  • Stock Information
  • Founded
  • KURA 2014
  • SPLP 1990
  • Country
  • KURA United States
  • SPLP United States
  • Employees
  • KURA N/A
  • SPLP N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • SPLP Industrial Specialties
  • Sector
  • KURA Health Care
  • SPLP Industrials
  • Exchange
  • KURA Nasdaq
  • SPLP Nasdaq
  • Market Cap
  • KURA 793.2M
  • SPLP 784.5M
  • IPO Year
  • KURA N/A
  • SPLP N/A
  • Fundamental
  • Price
  • KURA $7.26
  • SPLP $41.30
  • Analyst Decision
  • KURA Strong Buy
  • SPLP
  • Analyst Count
  • KURA 11
  • SPLP 0
  • Target Price
  • KURA $27.89
  • SPLP N/A
  • AVG Volume (30 Days)
  • KURA 1.7M
  • SPLP 2.6K
  • Earning Date
  • KURA 02-25-2025
  • SPLP 03-07-2025
  • Dividend Yield
  • KURA N/A
  • SPLP N/A
  • EPS Growth
  • KURA N/A
  • SPLP 28.01
  • EPS
  • KURA N/A
  • SPLP 9.74
  • Revenue
  • KURA N/A
  • SPLP $1,996,835,000.00
  • Revenue This Year
  • KURA N/A
  • SPLP N/A
  • Revenue Next Year
  • KURA $233.30
  • SPLP N/A
  • P/E Ratio
  • KURA N/A
  • SPLP $4.24
  • Revenue Growth
  • KURA N/A
  • SPLP 7.29
  • 52 Week Low
  • KURA $6.98
  • SPLP $33.12
  • 52 Week High
  • KURA $24.17
  • SPLP $48.45
  • Technical
  • Relative Strength Index (RSI)
  • KURA 19.21
  • SPLP 48.29
  • Support Level
  • KURA $7.02
  • SPLP $37.00
  • Resistance Level
  • KURA $7.66
  • SPLP $44.28
  • Average True Range (ATR)
  • KURA 0.34
  • SPLP 1.25
  • MACD
  • KURA 0.07
  • SPLP -0.24
  • Stochastic Oscillator
  • KURA 13.76
  • SPLP 53.75

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About SPLP Steel Partners Holdings LP LTD PARTNERSHIP UNIT

Steel Partners Holdings LP operates in industrial products, energy, defense, supply chain management and logistics, banking, and youth sports industries. It operates in various segments including the Diversified Industrial segment comprised of manufacturers of engineered niche industrial products, including joining materials, tubing, building materials, performance materials, electrical products, cutting replacement products and services, and metallized films and packaging businesses; the Energy segment provides drilling and production services to the oil and gas industry and owns a youth sports business; the Financial Services segment consists of the operations of WebBank, a Utah chartered industrial bank, which engages in full range of banking activities.

Share on Social Networks: